The Effect of Menopausal Hormone Therapies on Breast Cancer: Avoiding the Risk
- PMID: 26316245
- PMCID: PMC4555991
- DOI: 10.1016/j.ecl.2015.05.007
The Effect of Menopausal Hormone Therapies on Breast Cancer: Avoiding the Risk
Abstract
Estrogen and P treatment results in greater risk of breast cancer than placebo. Treatment with estrogen alone does not increase the risk of breast cancer, may be used by women who have had a hysterectomy, and may even result in a decreased risk of breast cancer. Continued research seeks to improve the understanding of the interplay between estrogen and progestogens that predispose to adverse effects on breast tissue. Caution over this hypothesized benefit is warranted until it is substantiated by data on the incidence of breast cancer in tissue selective estrogen complex users.
Keywords: Breast cancer; Estrogens; Hormone therapy; Menopause; Progestogen.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Hormone replacement therapy and cancer.Gynecol Endocrinol. 2001 Dec;15(6):453-65. Gynecol Endocrinol. 2001. PMID: 11826770 Review.
-
Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.Climacteric. 2001 Sep;4(3):181-93. Climacteric. 2001. PMID: 11588941 Review.
-
Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.Acta Endocrinol (Copenh). 1991;125 Suppl 1:13-26. Acta Endocrinol (Copenh). 1991. PMID: 1801500 Review.
-
The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.Maturitas. 2010 Jul;66(3):277-84. doi: 10.1016/j.maturitas.2010.03.011. Epub 2010 May 14. Maturitas. 2010. PMID: 20471761 Clinical Trial.
-
[Hormone substitution therapy in menopause and risk of breast cancer].Rev Fr Gynecol Obstet. 1991 Jan;86(1):27-8. Rev Fr Gynecol Obstet. 1991. PMID: 2068481 French.
Cited by
-
Hormone therapy use and breast tissue DNA methylation: analysis of epigenome wide data from the normal breast study.Epigenetics. 2019 Feb;14(2):146-157. doi: 10.1080/15592294.2019.1580111. Epub 2019 Mar 1. Epigenetics. 2019. PMID: 30821641 Free PMC article.
-
Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort study.Menopause. 2023 Aug 1;30(8):824-830. doi: 10.1097/GME.0000000000002217. Epub 2023 Jul 11. Menopause. 2023. PMID: 37449720 Free PMC article.
-
Identification of Candidate Genes in Breast Cancer Induced by Estrogen Plus Progestogens Using Bioinformatic Analysis.Int J Mol Sci. 2022 Oct 6;23(19):11892. doi: 10.3390/ijms231911892. Int J Mol Sci. 2022. PMID: 36233194 Free PMC article.
-
Breast cancer in low-middle income countries: abnormality in splicing and lack of targeted treatment options.Am J Cancer Res. 2020 May 1;10(5):1568-1591. eCollection 2020. Am J Cancer Res. 2020. PMID: 32509398 Free PMC article. Review.
References
-
- Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117(12):1016–1037. - PubMed
-
- Stefanick ML, Anderson GL, Margolis KL, et al. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. Jama. 2006;295(14):1647–1657. - PubMed
-
- Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003;362(9382):419–427. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical